Computed tomographic perfusion imaging for the prediction of response and survival to transarterial chemoembolization of hepatocellular carcinoma

Radiology and Oncology

Manca Garbajs¹  Rok Dezman¹  Assist. Prof. Peter Popovic²  Matjaz Bunc³  Ana Leban⁴  Klara Kregar⁵ 

[1] Clinical Institute of Radiology, University Medical Centre, Ljubljana, SloveniaOther articles by this author:;Corresponding authorClinical Institute of Radiology, University Medical Centre, Ljubljana, Slovenia;Department of Cardiology, University Medical Centre, Ljubljana, SloveniaOther articles by this author:;General Hospital Dr. Franca Derganca, Šempeter pri Gorici, SloveniaOther articles by this author:;General Hospital Jesenice, Jesenice, SloveniaOther articles by this author:

关键词: hepatocellular carcinoma;    computed tomography perfusion imaging;    drug-eluting beads transarterial chemoembolization;    response to treatment;    survival;   

DOI  :  10.1515/raon-2017-0052

学科分类：肿瘤学

来源: Onkoloski Institut Ljubljana / Institute of Oncology Ljubljana

【 摘 要 】

BackgroundThe purpose of this retrospective cohort study was to evaluate the clinical value of computed tomographic perfusion imaging (CTPI) parameters in predicting the response to treatment and overall survival in patients with hepatocellular carcinoma (HCC) treated with drug-eluting beads transarterial chemoembolization (DEBTACE).

【 授权许可】

Unknown